BrightPath Biotherapeutics Co Ltd (TSE:4594) Valuation:

BrightPath Biotherapeutics Co Ltd’s share price is 円51. Its GF Value is 円0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes BrightPath Biotherapeutics Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: 円51	GF Value	Price/GF Value
Current	円0	Infinity
Next FY1 End	円0	Infinity
Next 12 Month	円0	Infinity
Next FY2 End	円0	Infinity

Correlation Analysis

Summary:

GuruFocus performed a correlation analysis comparing BrightPath Biotherapeutics Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between BrightPath Biotherapeutics Co Ltd's stock price and Book Value per share, with a coefficient of 75%. BrightPath Biotherapeutics Co Ltd’s stock price shows no significant correlation with Revenue per share. BrightPath Biotherapeutics Co Ltd’s stock price shows no significant correlation with Operating Cash Flow per share. BrightPath Biotherapeutics Co Ltd’s stock price shows no significant correlation with Earnings without NRI per share.

Historical Trends of Key Valuation Ratios

GF Value of Related Companies

More Valuation Metrics

Intrinsic Value: DCF (Earnings Based) Intrinsic Value: DCF (FCF Based) Intrinsic Value: DCF (Dividend Based) Projected FCF Median PS Value Peter Lynch Fair Value Graham Number Earnings Power Value (EPV) Tangible Book per Share Net Current Asset Value Net Cash per Share Net-Net Working Capital

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.